169 related articles for article (PubMed ID: 22310977)
1. CIP2A overexpression is associated with c-Myc expression in colorectal cancer.
Böckelman C; Koskensalo S; Hagström J; Lundin M; Ristimäki A; Haglund C
Cancer Biol Ther; 2012 Mar; 13(5):289-95. PubMed ID: 22310977
[TBL] [Abstract][Full Text] [Related]
2. MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.
Khanna A; Böckelman C; Hemmes A; Junttila MR; Wiksten JP; Lundin M; Junnila S; Murphy DJ; Evan GI; Haglund C; Westermarck J; Ristimäki A
J Natl Cancer Inst; 2009 Jun; 101(11):793-805. PubMed ID: 19470954
[TBL] [Abstract][Full Text] [Related]
3. Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomy.
Chen KF; Yen CC; Lin JK; Chen WS; Yang SH; Jiang JK; Lan YT; Lin CC; Yu HC; Hsu HM; Lin WL; Teng HW
BMC Cancer; 2015 Apr; 15():301. PubMed ID: 25896895
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of CIP2A expression in serous ovarian cancer.
Böckelman C; Lassus H; Hemmes A; Leminen A; Westermarck J; Haglund C; Bützow R; Ristimäki A
Br J Cancer; 2011 Sep; 105(7):989-95. PubMed ID: 21897396
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth.
Liu N; He QM; Chen JW; Li YQ; Xu YF; Ren XY; Sun Y; Mai HQ; Shao JY; Jia WH; Kang TB; Zeng MS; Ma J
Mol Cancer; 2014 May; 13():111. PubMed ID: 24884612
[TBL] [Abstract][Full Text] [Related]
6. CIP2A is a predictor of poor prognosis in colon cancer.
Teng HW; Yang SH; Lin JK; Chen WS; Lin TC; Jiang JK; Yen CC; Li AF; Chen PC; Lan YT; Lin CC; Hsu YN; Wang HW; Chen KF
J Gastrointest Surg; 2012 May; 16(5):1037-47. PubMed ID: 22328001
[TBL] [Abstract][Full Text] [Related]
7. Effect of CIP2A and its mechanism of action in the malignant biological behavior of colorectal cancer.
Chen W; Liang JL; Zhou K; Zeng QL; Ye JW; Huang MJ
Cell Commun Signal; 2020 Apr; 18(1):67. PubMed ID: 32321509
[TBL] [Abstract][Full Text] [Related]
8. CIP2A is overexpressed in non-small cell lung cancer and correlates with poor prognosis.
Dong QZ; Wang Y; Dong XJ; Li ZX; Tang ZP; Cui QZ; Wang EH
Ann Surg Oncol; 2011 Mar; 18(3):857-65. PubMed ID: 20842459
[TBL] [Abstract][Full Text] [Related]
9. CIP2A regulates MYC translation (via its 5'UTR) in colorectal cancer.
Denk S; Schmidt S; Schurr Y; Schwarz G; Schote F; Diefenbacher M; Armendariz C; Dejure F; Eilers M; Wiegering A
Int J Colorectal Dis; 2021 May; 36(5):911-918. PubMed ID: 33078202
[TBL] [Abstract][Full Text] [Related]
10. CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma.
Xue Y; Wu G; Wang X; Zou X; Zhang G; Xiao R; Yuan Y; Long D; Yang J; Wu Y; Xu H; Liu F; Liu M
Med Oncol; 2013 Mar; 30(1):406. PubMed ID: 23275123
[TBL] [Abstract][Full Text] [Related]
11. CIP2A mediates prostate cancer progression via the c-Myc signaling pathway.
Guo Z; Liu D; Su Z
Tumour Biol; 2015 Jun; 36(6):4777-83. PubMed ID: 25636449
[TBL] [Abstract][Full Text] [Related]
12. CIP2A mediates prostate cancer progression via the c-MYC signaling pathway.
Guo Z; Liu D; Su Z
Tumour Biol; 2015 May; 36(5):3583-9. PubMed ID: 25560487
[TBL] [Abstract][Full Text] [Related]
13. CIP2A expression and prognostic role in patients with esophageal adenocarcinoma.
Rantanen T; Kauttu T; Åkerla J; Honkanen T; Krogerus L; Salo J; Paavonen T; Oksala N
Med Oncol; 2013; 30(3):684. PubMed ID: 23925667
[TBL] [Abstract][Full Text] [Related]
14. CIP2A is highly expressed in hepatocellular carcinoma and predicts poor prognosis.
He H; Wu G; Li W; Cao Y; Liu Y
Diagn Mol Pathol; 2012 Sep; 21(3):143-9. PubMed ID: 22847158
[TBL] [Abstract][Full Text] [Related]
15. [Expression of cancerous inhibitor of protein phosphatase 2A in tissue microarray of colorectal cancer and its clinical significance].
Peng XY; Chen W; Zhou K; Fu JP; Fu P; Zeng QL
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Nov; 16(11):1102-6. PubMed ID: 24277410
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic nexus of cancerous inhibitor of protein phosphatase 2A (CIP2A): an oncoprotein with many hands.
De P; Carlson J; Leyland-Jones B; Dey N
Oncotarget; 2014 Jul; 5(13):4581-602. PubMed ID: 25015035
[TBL] [Abstract][Full Text] [Related]
17. CIP2A influences survival in colon cancer and is critical for maintaining Myc expression.
Wiegering A; Pfann C; Uthe FW; Otto C; Rycak L; Mäder U; Gasser M; Waaga-Gasser AM; Eilers M; Germer CT
PLoS One; 2013; 8(10):e75292. PubMed ID: 24098375
[TBL] [Abstract][Full Text] [Related]
18. The association and prognostic relevance of cancerous inhibitor of protein phosphatase 2A and inflammation in tongue squamous cell carcinoma.
Seppälä M; Tervo S; Pohjola K; Laranne J; Huhtala H; Toppila-Salmi S; Paavonen T
APMIS; 2015 Dec; 123(12):1007-15. PubMed ID: 26522733
[TBL] [Abstract][Full Text] [Related]
19. Copy number increase of oncoprotein CIP2A is associated with poor patient survival in human head and neck squamous cell carcinoma.
Routila J; Bilgen T; Saramäki O; Grénman R; Visakorpi T; Westermarck J; Ventelä S
J Oral Pathol Med; 2016 May; 45(5):329-37. PubMed ID: 26436875
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor miR-375 regulates MYC expression via repression of CIP2A coding sequence through multiple miRNA-mRNA interactions.
Jung HM; Patel RS; Phillips BL; Wang H; Cohen DM; Reinhold WC; Chang LJ; Yang LJ; Chan EK
Mol Biol Cell; 2013 Jun; 24(11):1638-48, S1-7. PubMed ID: 23552692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
